Adcock Reports Slight Growth In A ‘Difficult Market’
Generics Business Sees Supply Challenges And Pricing Pressure
Adcock has made slight progress despite the effect of the current economic climate in South Africa on consumer spending and behavior.
You may also be interested in...
South Africa’s Aspen has made multiple strategic moves, including divesting its Japanese business to Sandoz and selling its local Phekolong Pharmaceuticals South African subsidiary to Laurus Labs, as part of efforts to better position itself in the face of “challenging” market conditions.
Teva has completed its portfolio of digital inhalers by launching a further two products, AirDuo Digihaler (fluticasone propionate/salmeterol) and ArmonAir Digihaler (fluticasone propionate), in the US. The pair join the firm’s previously launched ProAir Digihaler (albuterol sulfate).
Dr Reddy’s has announced the launch of its OTC versions of Pataday olopatadine solution in the US. The firm’s entry into the OTC eyecare space follows other OTC launches of rivals to Voltaren and Nicorette earlier this year.